Hypomagnesemia in Obese Subjects: Evidence of Systematic Review and Meta-analysis

Author(s): Kyria J.C. Cruz, Ana R.S. de Oliveira, Suelem T. de Freitas, Gilberto S. Henriques, Dilina do Nascimento Marreiro*

Journal Name: Current Nutrition & Food Science

Volume 16 , Issue 7 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Magnesium deficiency is a global nutritional problem which seems to influence obesity-associated metabolic disorders because magnesium plays an important role in the prevention and treatment of many diseases.

Objective: We conducted a systematic review and meta-analysis to evaluate the relationship between plasma magnesium concentrations and obesity.

Methods: A systematic review and meta-analysis of case-control studies was conducted. Relevant studies were identified from a literature search using electronic databases.

Results: Ten case-control studies were evaluated in this meta-analysis. Results demonstrated that obese individuals presented lower plasma magnesium concentration than healthy individuals (standardized mean difference [SMD] = -0.44, 95% confidence interval = -0.88 to -0.01). In subgroup analyses, there were differences in plasma magnesium concentration between obese and healthy individuals according to study location, gender, case age, control age, method for assessment of magnesium concentration and study quality. Furthermore, meta-regression analyses showed that the source of heterogeneity of magnesium levels among studies was control age.

Conclusion: Evidence of this systematic review and meta-analysis show hypomagnesemia in obese individuals of both genders.

Keywords: Human, hypomagnesemia, magnesium, obesity, observational study, review.

[1]
García EA. Obesidade, tecido adiposo e resistência à insulina. Acta Bioquim Clin Latinoam 2012; 46(2): 183-94.
[2]
Savini I, Catani MV, Evangelista D, Gasperi V, Avigliano L. Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci 2013; 14(5): 10497-538.
[http://dx.doi.org/10.3390/ijms140510497] [PMID: 23698776]
[3]
Farhanghi MA, Mahboob S, Ostadrahimi A. Obesity induced magnesium deficiency can be treated by vitamin D supplementation. J Pak Med Assoc 2009; 59(4): 258-61.
[PMID: 19402296]
[4]
Farhangi MA, Ostadrahimi A, Mahboob S. Serum calcium, magnesium, phosphorous and lipid profile in healthy Iranian premenopausal women. Biochem Med (Zagreb) 2011; 21(3): 312-20.
[http://dx.doi.org/10.11613/BM.2011.042] [PMID: 22420246]
[5]
Instituto Brasileiro de Geografia e Estatística; Pesquisa de orçamentos familiares 2008-2009: Análise do consumo alimentarpessoal no Brasil. Rio de janeiro: IBGE, Coordenação de Trabalho e Rendimento. 2011.[Online] 2011 [cited 2018]. Available from:. https://biblioteca.ibge.gov.br/visualizacao/livros/liv50063.pdf
[6]
de Oliveira AR, Cruz KJC, Morais JB, et al. Magnesium status and its relationship with C-reactive protein in obese women. Biol Trace Elem Res 2015; 168(2): 296-302.
[http://dx.doi.org/10.1007/s12011-015-0358-8] [PMID: 25982004]
[7]
Morais JBS, Severo JS, de Oliveira ARS, et al. Magnesium status and its association with oxidative stress in obese women. Biol Trace Elem Res 2017; 175(2): 306-11.
[http://dx.doi.org/10.1007/s12011-016-0797-x] [PMID: 27406212]
[8]
Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride.Washington, DC: National Academy Press 1997.
[9]
Muñoz-Castañeda JR, Pendón-Ruiz de Mier MV, Rodríguez M, Rodríguez-Ortiz ME. Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials. Int J Mol Sci 2018; 19(3)E664
[http://dx.doi.org/10.3390/ijms19030664] [PMID: 29495444]
[10]
Severo JS, Morais JBS, Freitas TEC, et al. Aspectos Metabólicos e Nutricionais do Magnésio. Nutr Clín Diet Hosp 2015; 35(2): 67-74.
[11]
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008-12.
[http://dx.doi.org/10.1001/jama.283.15.2008] [PMID: 10789670]
[12]
Ministério da Saúde; Diretrizes metodológicas – elaboração de revisão sistemática e metanálise de estudos observacionais. Brasília: Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Ciência e Tecnologia. 2014.[Online] 2014 [cited 2018]. Available from:. bvsms.saude.gov.br/bvs/.../diretrizes_metodologicas_fatores_risco_prognostico.pdf
[13]
Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 2018]. Available from:. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
[14]
Hedges LV. Distribution Theory for glass’s estimator of effect size and related estimators. J Educ Stat 1981; 6(2): 107-28.
[15]
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7(3): 177-88.
[http://dx.doi.org/10.1016/0197-2456(86)90046-2] [PMID: 3802833]
[16]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-34.
[http://dx.doi.org/10.1136/bmj.315.7109.629] [PMID: 9310563]
[17]
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50(4): 1088-101.
[http://dx.doi.org/10.2307/2533446] [PMID: 7786990]
[18]
R Development Core Team; R: a language and environment for statistical computing. Vienna, Austria: the R Foundation for Statistical Computing. [cited 2018]. Available from:. http://www.R-project.org/
[19]
Corica F, Allegra A, Ientile R, et al. Changes in plasma, erythrocyte, and platelet magnesium levels in normotensive and hypertensive obese subjects during oral glucose tolerance test. Am J Hypertens 1999; 12(2 Pt 1): 128-36.
[http://dx.doi.org/10.1016/S0895-7061(98)00174-5] [PMID: 10090339]
[20]
Cruz KJC, de Oliveira AR, Pinto DP, et al. Influence of magnesium on insulin resistance in obese women. Biol Trace Elem Res 2014; 160(3): 305-10.
[http://dx.doi.org/10.1007/s12011-014-0044-2] [PMID: 24984789]
[21]
Guerrero-Romero F, Rodríguez-Morán M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord 2002; 26(4): 469-74.
[http://dx.doi.org/10.1038/sj.ijo.0801954] [PMID: 12075573]
[22]
Guerrero-Romero F, Flores-García A, Saldaña-Guerrero S, Simental-Mendía LE, Rodríguez-Morán M. Obesity and hypomagnesemia. Eur J Intern Med 2016; 34: 29-33.
[http://dx.doi.org/10.1016/j.ejim.2016.06.015] [PMID: 27353277]
[23]
Rodríguez-Hernández H, Gonzalez JL, Rodríguez-Morán M, Guerrero-Romero F. Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects. Arch Med Res 2005; 36(4): 362-6.
[http://dx.doi.org/10.1016/j.arcmed.2005.03.008] [PMID: 15950075]
[24]
Rodriguez-Morán M, Guerrero-Romero F. Elevated concentrations of TNF-alpha are related to low serum magnesium levels in obese subjects. Magnes Res 2004; 17(3): 189-96.
[PMID: 15724867]
[25]
Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007; 458(1): 40-7.
[http://dx.doi.org/10.1016/j.abb.2006.05.007] [PMID: 16808892]
[26]
Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA. Magnesium transport in the renal distal convoluted tubule. Physiol Rev 2001; 81(1): 51-84.
[http://dx.doi.org/10.1152/physrev.2001.81.1.51] [PMID: 11152754]
[27]
Quamme GA. Renal magnesium handling: new insights in understanding old problems. Kidney Int 1997; 52(5): 1180-95.
[http://dx.doi.org/10.1038/ki.1997.443] [PMID: 9350641]
[28]
Lecube A, Baena-Fustegueras JA, Fort JM, Pelegrí D, Hernández C, Simó R. Diabetes is the main factor accounting for hypomagnesemia in obese subjects. PLoS One 2012; 7(1)e30599
[http://dx.doi.org/10.1371/journal.pone.0030599] [PMID: 22291997]
[29]
Lima Mde L, Cruz T, Rodrigues LE, et al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome--evidences for its relation to insulin resistance. Diabetes Res Clin Pract 2009; 83(2): 257-62.
[http://dx.doi.org/10.1016/j.diabres.2008.11.019] [PMID: 19124169]
[30]
Nair AV, Hocher B, Verkaart S, et al. Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy. Proc Natl Acad Sci USA 2012; 109(28): 11324-9.
[http://dx.doi.org/10.1073/pnas.1113811109] [PMID: 22733750]
[31]
Cruz KJC, de Oliveira ARS, Morais JBS, et al. Zinc and insulin resistance: biochemical and molecular aspects. Biol Trace Elem Res 2018; 186(2): 407-12.
[http://dx.doi.org/10.1007/s12011-018-1308-z] [PMID: 29564656]
[32]
Nielsen FH. Magnesium deficiency and increased inflammation: current perspectives. J Inflamm Res 2018; 11(11): 25-34.
[http://dx.doi.org/10.2147/JIR.S136742] [PMID: 29403302]
[33]
Oliveira ARS, Cruz KJC, Severo JS, et al. Hypomagnesemia and its relation with chronic low-grade inflammation in obesity. Rev Assoc Med Bras (1992). 2017; 63(2): 156-63.
[http://dx.doi.org/10.1590/1806-9282.63.02.156] [PMID: 28355377]
[34]
Morales-Ruán Mdel C, Villalpando S, García-Guerra A, et al. Iron, zinc, copper and magnesium nutritional status in Mexican children aged 1 to 11 years. Salud Publica Mex 2012; 54(2): 125-34.
[http://dx.doi.org/10.1590/S0036-36342012000200008] [PMID: 22535171]
[35]
De la Cruz-Góngora V, Gaona B, Villalpando S, Shamah-Levy T, Robledo R. Anemia and iron, zinc, copper and magnesium deficiency in Mexican adolescents: National Health and Nutrition Survey 2006. Salud Publica Mex 2012; 54(2): 135-45.
[http://dx.doi.org/10.1590/S0036-36342012000200009] [PMID: 22535172]
[36]
Mejía-Rodríguez F, Shamah-Levy T, Villalpando S, García-Guerra A, Méndez-Gómez Humarán I. Iron, zinc, copper and magnesium deficiencies in Mexican adults from the National Health and Nutrition Survey 2006. Salud Publica Mex 2013; 55(3): 275-84.
[http://dx.doi.org/10.21149/spm.v55i3.7210] [PMID: 23912540]
[37]
Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J 2012; 5(Suppl. 1): i3-i14.
[http://dx.doi.org/10.1093/ndtplus/sfr163] [PMID: 26069819]
[38]
Barbagallo M, Dominguez LJ. Magnesium and aging. Curr Pharm Des 2010; 16(7): 832-9.
[http://dx.doi.org/10.2174/138161210790883679] [PMID: 20388094]
[39]
Scalabrini AC, Ribeiro VFCA. Comparação entre métodos analíticos na dosagem de magnésio em hospital universitário do interior do estado de São Paulo. São Paulo: Faculdade de Medicina de Ribeirão Preto 2012.
[40]
Dibaba DT, Xun P, Fly AD, Yokota K, He K. Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis. Diabet Med 2014; 31(11): 1301-9.
[http://dx.doi.org/10.1111/dme.12537] [PMID: 24975384]
[41]
Sarrafzadegan N, Khosravi-Boroujeni H, Lotfizadeh M, Pourmogaddas A, Salehi-Abargouei A. Magnesium status and the metabolic syndrome: a systematic review and meta-analysis. Nutrition 2016; 32(4): 409-17.
[http://dx.doi.org/10.1016/j.nut.2015.09.014] [PMID: 26919891]
[42]
La SA, Lee JY, Kim DH, Song EL, Park JH, Ju SY. Low magnesium levels in adults with metabolic syndrome: a meta-analysis. Biol Trace Elem Res 2016; 170(1): 33-42.
[http://dx.doi.org/10.1007/s12011-015-0446-9] [PMID: 26208810]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 7
Year: 2020
Page: [1044 - 1051]
Pages: 8
DOI: 10.2174/1573401315666190821110459
Price: $65

Article Metrics

PDF: 23
HTML: 1